Table of Content

1 Liposomal Bupivacaine Market Overview
1.1 Product Overview and Scope of Liposomal Bupivacaine
1.2 Liposomal Bupivacaine Segment by Type
1.2.1 Global Liposomal Bupivacaine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 20ml
1.2.3 10ml
1.3 Liposomal Bupivacaine Segment by Application
1.3.1 Liposomal Bupivacaine Sales Comparison by Application: (2021-2027)
1.3.2 Veterinary
1.3.3 Human
1.4 Global Liposomal Bupivacaine Market Size Estimates and Forecasts
1.4.1 Global Liposomal Bupivacaine Revenue 2016-2027
1.4.2 Global Liposomal Bupivacaine Sales 2016-2027
1.4.3 Liposomal Bupivacaine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Liposomal Bupivacaine Market Competition by Manufacturers
2.1 Global Liposomal Bupivacaine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Liposomal Bupivacaine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Liposomal Bupivacaine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Liposomal Bupivacaine Manufacturing Sites, Area Served, Product Type
2.5 Liposomal Bupivacaine Market Competitive Situation and Trends
2.5.1 Liposomal Bupivacaine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Liposomal Bupivacaine Players Market Share by Revenue
2.5.3 Global Liposomal Bupivacaine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Liposomal Bupivacaine Retrospective Market Scenario by Region
3.1 Global Liposomal Bupivacaine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Liposomal Bupivacaine Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Liposomal Bupivacaine Market Facts & Figures by Country
3.3.1 North America Liposomal Bupivacaine Sales by Country
3.3.2 North America Liposomal Bupivacaine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Liposomal Bupivacaine Market Facts & Figures by Country
3.4.1 Europe Liposomal Bupivacaine Sales by Country
3.4.2 Europe Liposomal Bupivacaine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Liposomal Bupivacaine Market Facts & Figures by Region
3.5.1 Asia Pacific Liposomal Bupivacaine Sales by Region
3.5.2 Asia Pacific Liposomal Bupivacaine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Liposomal Bupivacaine Market Facts & Figures by Country
3.6.1 Latin America Liposomal Bupivacaine Sales by Country
3.6.2 Latin America Liposomal Bupivacaine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Liposomal Bupivacaine Market Facts & Figures by Country
3.7.1 Middle East and Africa Liposomal Bupivacaine Sales by Country
3.7.2 Middle East and Africa Liposomal Bupivacaine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Liposomal Bupivacaine Historic Market Analysis by Type
4.1 Global Liposomal Bupivacaine Sales Market Share by Type (2016-2021)
4.2 Global Liposomal Bupivacaine Revenue Market Share by Type (2016-2021)
4.3 Global Liposomal Bupivacaine Price by Type (2016-2021)

5 Global Liposomal Bupivacaine Historic Market Analysis by Application
5.1 Global Liposomal Bupivacaine Sales Market Share by Application (2016-2021)
5.2 Global Liposomal Bupivacaine Revenue Market Share by Application (2016-2021)
5.3 Global Liposomal Bupivacaine Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Pacira Pharmaceuticals
6.1.1 Pacira Pharmaceuticals Corporation Information
6.1.2 Pacira Pharmaceuticals Description and Business Overview
6.1.3 Pacira Pharmaceuticals Liposomal Bupivacaine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Pacira Pharmaceuticals Product Portfolio
6.1.5 Pacira Pharmaceuticals Recent Developments/Updates

7 Liposomal Bupivacaine Manufacturing Cost Analysis
7.1 Liposomal Bupivacaine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Liposomal Bupivacaine
7.4 Liposomal Bupivacaine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Liposomal Bupivacaine Distributors List
8.3 Liposomal Bupivacaine Customers

9 Liposomal Bupivacaine Market Dynamics
9.1 Liposomal Bupivacaine Industry Trends
9.2 Liposomal Bupivacaine Growth Drivers
9.3 Liposomal Bupivacaine Market Challenges
9.4 Liposomal Bupivacaine Market Restraints

10 Global Market Forecast
10.1 Liposomal Bupivacaine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Liposomal Bupivacaine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Liposomal Bupivacaine by Type (2022-2027)
10.2 Liposomal Bupivacaine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Liposomal Bupivacaine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Liposomal Bupivacaine by Application (2022-2027)
10.3 Liposomal Bupivacaine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Liposomal Bupivacaine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Liposomal Bupivacaine by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Liposomal Bupivacaine Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Liposomal Bupivacaine Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Liposomal Bupivacaine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Liposomal Bupivacaine Covered in This Study
Table 5. Global Liposomal Bupivacaine Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Liposomal Bupivacaine Sales Share by Manufacturers (2016-2021)
Table 7. Global Liposomal Bupivacaine Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Liposomal Bupivacaine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Liposomal Bupivacaine Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Liposomal Bupivacaine Manufacturing Sites and Area Served
Table 11. Manufacturers Liposomal Bupivacaine Product Type
Table 12. Global Liposomal Bupivacaine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Liposomal Bupivacaine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liposomal Bupivacaine as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Liposomal Bupivacaine Sales by Region (2016-2021) & (K Units)
Table 16. Global Liposomal Bupivacaine Sales Market Share by Region (2016-2021)
Table 17. Global Liposomal Bupivacaine Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Liposomal Bupivacaine Sales by Country (2016-2021) & (K Units)
Table 19. North America Liposomal Bupivacaine Sales Market Share by Country (2016-2021)
Table 20. North America Liposomal Bupivacaine Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Liposomal Bupivacaine Revenue Market Share by Country (2016-2021)
Table 22. Europe Liposomal Bupivacaine Sales by Country (2016-2021) & (K Units)
Table 23. Europe Liposomal Bupivacaine Sales Market Share by Country (2016-2021)
Table 24. Europe Liposomal Bupivacaine Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Liposomal Bupivacaine Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Liposomal Bupivacaine Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Liposomal Bupivacaine Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Liposomal Bupivacaine Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Liposomal Bupivacaine Revenue Market Share by Region (2016-2021)
Table 30. Latin America Liposomal Bupivacaine Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Liposomal Bupivacaine Sales Market Share by Country (2016-2021)
Table 32. Latin America Liposomal Bupivacaine Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Liposomal Bupivacaine Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Liposomal Bupivacaine Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Liposomal Bupivacaine Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Liposomal Bupivacaine Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Liposomal Bupivacaine Revenue Market Share by Country (2016-2021)
Table 38. Global Liposomal Bupivacaine Sales (K Units) by Type (2016-2021)
Table 39. Global Liposomal Bupivacaine Sales Market Share by Type (2016-2021)
Table 40. Global Liposomal Bupivacaine Revenue (Million US$) by Type (2016-2021)
Table 41. Global Liposomal Bupivacaine Revenue Share by Type (2016-2021)
Table 42. Global Liposomal Bupivacaine Price (US$/Unit) by Type (2016-2021)
Table 43. Global Liposomal Bupivacaine Sales (K Units) by Application (2016-2021)
Table 44. Global Liposomal Bupivacaine Sales Market Share by Application (2016-2021)
Table 45. Global Liposomal Bupivacaine Revenue (Million US$) by Application (2016-2021)
Table 46. Global Liposomal Bupivacaine Revenue Share by Application (2016-2021)
Table 47. Global Liposomal Bupivacaine Price (US$/Unit) by Application (2016-2021)
Table 48. Pacira Pharmaceuticals Corporation Information
Table 49. Pacira Pharmaceuticals Description and Business Overview
Table 50. Pacira Pharmaceuticals Liposomal Bupivacaine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Pacira Pharmaceuticals Liposomal Bupivacaine Product
Table 52. Pacira Pharmaceuticals Recent Developments/Updates
Table 53. Production Base and Market Concentration Rate of Raw Material
Table 54. Key Suppliers of Raw Materials
Table 55. Liposomal Bupivacaine Distributors List
Table 56. Liposomal Bupivacaine Customers List
Table 57. Liposomal Bupivacaine Market Trends
Table 58. Liposomal Bupivacaine Growth Drivers
Table 59. Liposomal Bupivacaine Market Restraints
Table 60. Global Liposomal Bupivacaine Sales Forecast by Type (2022-2027) & (K Units)
Table 61. Global Liposomal Bupivacaine Sales Market Share Forecast by Type (2022-2027)
Table 62. Global Liposomal Bupivacaine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 63. Global Liposomal Bupivacaine Revenue Market Share Forecast by Type (2022-2027)
Table 64. Global Liposomal Bupivacaine Sales Forecast by Application (2022-2027) & (K Units)
Table 65. Global Liposomal Bupivacaine Sales Market Share Forecast by Application (2022-2027)
Table 66. Global Liposomal Bupivacaine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 67. Global Liposomal Bupivacaine Revenue Market Share Forecast by Application (2022-2027)
Table 68. Global Liposomal Bupivacaine Sales Forecast by Region (2022-2027) & (K Units)
Table 69. Global Liposomal Bupivacaine Sales Market Share Forecast by Region (2022-2027)
Table 70. Global Liposomal Bupivacaine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 71. Global Liposomal Bupivacaine Revenue Market Share Forecast by Region (2022-2027)
Table 72. Research Programs/Design for This Report
Table 73. Key Data Information from Secondary Sources
Table 74. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Liposomal Bupivacaine
Figure 2. Global Liposomal Bupivacaine Market Share by Type in 2020 & 2027
Figure 3. 20ml Product Picture
Figure 4. 10ml Product Picture
Figure 5. Global Liposomal Bupivacaine Market Share by Application in 2020 & 2027
Figure 6. Veterinary
Figure 7. Human
Figure 8. Global Liposomal Bupivacaine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Liposomal Bupivacaine Market Size 2016-2027 (US$ Million)
Figure 10. Global Liposomal Bupivacaine Sales 2016-2027 (K Units)
Figure 11. Global Liposomal Bupivacaine Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Liposomal Bupivacaine Sales Share by Manufacturers in 2020
Figure 13. Global Liposomal Bupivacaine Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Liposomal Bupivacaine Players: Market Share by Revenue in 2020
Figure 15. Liposomal Bupivacaine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Liposomal Bupivacaine Sales Market Share by Region (2016-2021)
Figure 17. Global Liposomal Bupivacaine Sales Market Share by Region in 2020
Figure 18. Global Liposomal Bupivacaine Revenue Market Share by Region (2016-2021)
Figure 19. Global Liposomal Bupivacaine Revenue Market Share by Region in 2020
Figure 20. U.S. Liposomal Bupivacaine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Liposomal Bupivacaine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Liposomal Bupivacaine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Liposomal Bupivacaine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Liposomal Bupivacaine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Liposomal Bupivacaine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Liposomal Bupivacaine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Liposomal Bupivacaine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Liposomal Bupivacaine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Liposomal Bupivacaine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Liposomal Bupivacaine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Liposomal Bupivacaine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan Liposomal Bupivacaine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Liposomal Bupivacaine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Liposomal Bupivacaine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Liposomal Bupivacaine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines Liposomal Bupivacaine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam Liposomal Bupivacaine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Liposomal Bupivacaine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Liposomal Bupivacaine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Liposomal Bupivacaine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Liposomal Bupivacaine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Liposomal Bupivacaine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. UAE Liposomal Bupivacaine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Liposomal Bupivacaine by Type (2016-2021)
Figure 45. Sales Market Share of Liposomal Bupivacaine by Application (2016-2021)
Figure 46. Sales Market Share of Liposomal Bupivacaine by Application in 2020
Figure 47. Revenue Share of Liposomal Bupivacaine by Application (2016-2021)
Figure 48. Revenue Share of Liposomal Bupivacaine by Application in 2020
Figure 49. Manufacturing Cost Structure of Liposomal Bupivacaine
Figure 50. Manufacturing Process Analysis of Liposomal Bupivacaine
Figure 51. Liposomal Bupivacaine Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed